Table 3 Risk factors and protective factors in patients with and without dementia.
Model 2 | Model 3 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No Dementia | Dementia | No Dementia | Dementia | ||||||
OR(95%CI) | p | OR(95%CI) | p | OR(95%CI) | p | OR(95%CI) | p | ||
Outcome: nosocomial infections | |||||||||
Sex M | 1.50(1.01–2.23) | 0.046 | 1.25(0.81–1.94) | 0.309 | Sex M | 1.33(0.90–1.95) | 0.152 | 1.23(0.80–1.89) | 0.350 |
Age | 1.06(1.03–1.10) | < 0.001 | 1.04(1.00–1.07) | 0.048 | Age | 1.08(1.05–1.11) | < 0.001 | 1.04(1.00–1.07) | 0.026 |
Stroke | 1.38(0.89–2.13) | 0.146 | 2.48(1.47–4.19) | 0.001 | Stroke | 1.51(0.99–2.29) | 0.054 | 2.55(1.53–4.27) | < 0.001 |
Diabetes | 0.90(0.56–1.43) | 0.648 | 0.84(0.49–1.44) | 0.524 | Diabetes | 0.88(0.56–1.39) | 0.584 | 0.89(0.52–1.53) | 0.683 |
Antipsychotic drugs | 1.16(0.58–2.28) | 0.677 | 1.03(0.65–1.63) | 0.897 | Antipsychotic drugs | 1.28(0.66–2.48) | 0.466 | 1.07(0.68–1.69) | 0.765 |
CVC | 3.01(0.82–11.09) | 0.097 | 2.81(0.81–9.79) | 0.104 | days CVC | 1.01(0.97–1.05) | 0.680 | 1.06(0.95–1.18) | 0.304 |
Power Glide | 0.56(0.05–5.90) | 0.630 | 0.18(0.01–3.71) | 0.270 | days Power Glide | 1.06(0.05–20.76) | 0.969 | 0.81(0.48–1.36) | 0.420 |
PVC | 1.69(1.12–2.55) | 0.013 | 1.52(0.94–2.46) | 0.090 | days PVC | 1.00(1.00–1.00) | 0.693 | 1.00(0.99–1.01) | 0.536 |
PICC | 0.55(0.17–1.75) | 0.309 | 1.00(0.31–3.26) | 0.997 | days PICC | 1.00(0.98–1.02) | 0.987 | 1.01(0.91–1.13) | 0.796 |
Nasogastric tube | 6.22(2.40–16.08) | < 0.001 | 0.99(0.41–2.42) | 0.990 | days Nasogastric tube | 1.01(0.95–1.07) | 0.846 | 1.01(0.97–1.04) | 0.782 |
Midline | 4.41(1.49–13.03) | 0.007 | 1.85(0.74–4.58) | 0.186 | days Midline | 1.36(1.08–1.70) | 0.008 | 1.05(0.94–1.16) | 0.376 |
Urinary catheter | 7.17(4.21–12.22) | < 0.001 | 3.35(1.94–5.78) | < 0.001 | days Urinary catheter | 1.09(1.07–1.11) | < 0.001 | 1.04(1.02–1.06) | < 0.001 |
_cons | 0.00(0.00–0.00) | < 0.001 | 0.01(0.00–0.11) | 0.001 | _cons | 0.00(0.00–0.00) | < 0.001 | 0.01(0.00–0.11) | 0.001 |
Outcome: pneumonia | |||||||||
Sex M | 2.02(1.23–3.32) | 0.005 | 2.69(1.62–4.48) | < 0.001 | Sex M | 1.74(1.09–2.79) | 0.021 | 2.61(1.57–4.34) | < 0.001 |
Age | 1.08(1.04–1.12) | < 0.001 | 1.03(0.99–1.07) | 0.166 | Age | 1.08(1.05–1.13) | < 0.001 | 1.03(0.99–1.07) | 0.164 |
Stroke | 1.27(0.75–2.15) | 0.374 | 3.03(1.67–5.48) | < 0.001 | Stroke | 1.37(0.82–2.27) | 0.227 | 3.16(1.75–5.72) | < 0.001 |
Diabetes | 0.59(0.31–1.11) | 0.101 | 0.66(0.34–1.29) | 0.221 | Diabetes | 0.61(0.33–1.14) | 0.121 | 0.66(0.34–1.28) | 0.217 |
Antipsychotic drugs | 1.13(0.50–2.57) | 0.776 | 0.91(0.52–1.58) | 0.731 | Antipsychotic drugs | 1.01(0.44–2.31) | 0.985 | 0.90(0.52–1.58) | 0.726 |
Nasogastric tube | 16.06(7.05–36.57) | < 0.001 | 1.98(0.79–4.99) | 0.146 | days Nasogastric tube | 1.09(1.04–1.15) | < 0.001 | 1.03(1.00–1.06) | 0.046 |
_cons | 0.00(0.00–0.00) | < 0.001 | 0.00(0.00–0.10) | 0.001 | _cons | 0.00(0.00–0.00) | < 0.001 | 0.00(0.00–0.10) | 0.001 |
Outcome: urinary tract infections | |||||||||
Sex M | 0.78(0.49–1.25) | 0.311 | 0.53(0.28–1.00) | 0.049 | Sex M | 0.75(0.47–1.19) | 0.222 | 0.53(0.28–1.00) | 0.049 |
Age | 1.05(1.01–1.08) | 0.010 | 1.05(1.00–1.10) | 0.035 | Age | 1.06(1.02–1.09) | 0.002 | 1.05(1.01–1.10) | 0.029 |
Stroke | 1.47(0.90–2.40) | 0.123 | 1.64(0.84–3.19) | 0.145 | Stroke | 1.33(0.81–2.18) | 0.256 | 1.72(0.89–3.33) | 0.104 |
Diabetes | 0.92(0.53–1.58) | 0.752 | 0.99(0.48–2.04) | 0.972 | Diabetes | 0.92(0.53–1.58) | 0.761 | 0.96(0.47–1.98) | 0.922 |
Antipsychotic drugs | 1.42(0.67–2.98) | 0.358 | 1.30(0.73–2.33) | 0.375 | Antipsychotic drugs | 1.48(0.72–3.06) | 0.290 | 1.28(0.72–2.29) | 0.397 |
Urinary catheter | 7.10(4.28–11.78) | < 0.001 | 3.81(2.05–7.07) | < 0.001 | Days Urinary catheter | 1.07(1.05–1.09) | < 0.001 | 1.04(1.01–1.06) | 0.004 |
_cons | 0.00(0.00–0.05) | < 0.001 | 0.00(0.00–0.16) | 0.005 | _cons | 0.00(0.00–0.03) | < 0.001 | 0.00(0.00–0.15) | 0.005 |
Outcome: bloodstream infections | |||||||||
Sex M | 0.98(0.28–3.39) | 0.977 | 0.50(0.08–3.03) | 0.454 | Sex M | 0.93(0.27–3.27) | 0.912 | 0.58(0.10–3.50) | 0.554 |
Age | 1.05(0.95–1.15) | 0.361 | 1.06(0.92–1.22) | 0.421 | Age | 1.01(0.92–1.10) | 0.885 | 1.07(0.92–1.25) | 0.376 |
Stroke | 2.33(0.70–7.81) | 0.170 | 1.12(0.17–7.23) | 0.907 | Stroke | 2.59(0.77–8.69) | 0.125 | 1.14(0.17–7.59) | 0.894 |
Diabetes | 0.54(0.09–3.09) | 0.488 | 1.42(0.23–8.73) | 0.703 | Diabetes | 0.34(0.05–2.36) | 0.273 | 1.53(0.23–10.03) | 0.655 |
Antipsychotic drugs | 5.06(1.36–18.77) | 0.015 | 2.24(0.51–9.78) | 0.284 | Antipsychotic drugs | 5.72(1.54–21.26) | 0.009 | 1.90(0.39–9.26) | 0.429 |
CVC | 13.11(2.54–67.76) | 0.002 | 3.97(0.19–84.93) | 0.378 | days CVC | 1.08(1.03–1.14) | 0.002 | 1.16(0.98–1.36) | 0.080 |
Power Glide | 5.85(0.18–190.96) | 0.320 | 7.65(0.30–192.31) | 0.216 | days Power Glide | 6.96(0.21–225.96) | 0.275 | 1.40(0.85–2.30) | 0.188 |
PVC | 1.35(0.36–5.09) | 0.662 | 0.77(0.16–3.60) | 0.736 | days PVC | 1.00(1.00–1.00) | 0.035 | 1.01(1.00–1.02) | 0.173 |
PICC | 0.99(0.05–18.66) | 0.993 | 2.26(0.10–50.18) | 0.605 | days PICC | 1.01(1.00–1.03) | 0.142 | 1.13(0.99–1.28) | 0.073 |
Midline | 9.05(1.77–46.21) | 0.008 | 5.42(0.84–34.88) | 0.075 | days Midline | 1.27(1.08–1.48) | 0.004 | 1.18(1.05–1.32) | 0.007 |
_cons | 0.00(0.00–0.85) | 0.046 | 0.00(0.00–64.60) | 0.187 | _cons | 0.01(0.00–15.65) | 0.198 | 0.00(0.00–47.92) | 0.157 |
